Facial Rejuvenation Market Report 2026

The facial rejuvenation market size has grown rapidly in recent years. It will grow from $3.44 billion in 2025 to $3.84 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to aging population growth, rising beauty consciousness, expansion of cosmetic clinics, technological advancements in skin treatments, increasing disposable income.

The facial rejuvenation market size is expected to see rapid growth in the next few years. It will grow to $5.66 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to innovation in energy-based devices, demand for personalized skincare, growth in minimally invasive treatments, increasing male aesthetic adoption, expansion of dermatology services. Major trends in the forecast period include rising demand for anti-aging treatments, growing popularity of non-invasive procedures, increased use of combination rejuvenation therapies, expansion of medical aesthetic centers, adoption of advanced skin rejuvenation devices.

The growing demand for non-invasive facial surgical procedures is expected to drive the expansion of the facial rejuvenation market. Non-invasive facial procedures are cosmetic treatments designed to enhance facial appearance without surgery or large incisions. The increasing popularity of these procedures is attributed to minimal downtime, reduced invasiveness, lower risk, and natural-looking results. Facial rejuvenation uses such noninvasive methods to lessen the appearance of wrinkles and fine lines by temporarily relaxing the muscles that cause them. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional organization, reported that nonsurgical facial rejuvenation procedures reached 19,182,141 globally in 2023, reflecting a 1.7% increase compared to 2022. Therefore, the rising demand for non-invasive facial surgical procedures is anticipated to drive the growth of the facial rejuvenation market.

Leading companies in the facial rejuvenation market are focusing on developing innovative treatments, such as permanent hair reduction and skin rejuvenation therapies, to meet growing demand for non-invasive and minimally invasive cosmetic procedures. These advanced treatments aim to enhance skin appearance and health while reducing unwanted hair growth. For instance, in March 2024, Reveal Lasers LLC, a US-based manufacturer of aesthetic laser and RF devices, launched the AlloraPro Laser Workstation, a state-of-the-art device designed for permanent hair reduction and skin rejuvenation treatments. The AlloraPro features an intuitive interface and customizable treatment settings, offering a 25% larger spot size for improved efficiency. It can also address vascular lesions, including leg and facial veins, as well as pigmented lesions and photorejuvenation. With adjustable pulse width, fluence, repetition rate, an automatic spot recognition system, and convenient handpiece storage, the AlloraPro Laser Workstation provides a versatile, effective, and profitable solution for aesthetic practices worldwide.

In February 2025, Crown Laboratories, Inc., a US-based privately held skincare and medical aesthetics company, acquired Revance Therapeutics, Inc., for an enterprise value of $924 million. This acquisition enables Crown to vertically integrate and scale its facial aesthetics business by combining its extensive skin health product portfolio with Revance’s leading injectable platform. Revance, headquartered in Tennessee, is a US-based biotech firm specializing in aesthetic injectables, including DAXXIFY (daxibotulinumtoxinA) and the RHA dermal filler collection.

Major companies operating in the facial rejuvenation market are AbbVie Inc., Bausch Health Companies Inc., Galderma S/A, Contura International A/S, Hologic Inc., Fibrocell Science Inc., Merz Pharma GmbH & Co. KGaA, InMode Ltd., Lumenis Ltd., Cynosure LLC, Cutera Inc., Lutronic Corporation, Anika Therapeutics Inc., Croma-Pharma GmbH, Revance Therapeutics Inc., Sciton Inc., Alma Lasers, Venus Concept Ltd., Zimmer MedizinSystems, Ulthera Inc., Jeisys Medical Inc., Lynton Lasers Ltd., Candela Corporation, Revance Aesthetics Inc.

North America was the largest region in the facial rejuvenation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the facial rejuvenation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the facial rejuvenation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the facial rejuvenation market by raising prices for imported laser devices, RF equipment, injectables, and skincare formulations. Beauty clinics and dermatology centers in Asia-Pacific and emerging markets are most impacted due to reliance on global aesthetic technology suppliers. These higher costs can limit consumer access to advanced cosmetic procedures. However, tariffs are encouraging local manufacturing of devices and skincare products, strengthening regional market growth.

The facial rejuvenation market research report is one of a series of new reports that provides facial rejuvenation market statistics, including facial rejuvenation industry global market size, regional shares, competitors with a facial rejuvenation market share, detailed facial rejuvenation market segments, market trends and opportunities, and any further data you may need to thrive in the facial rejuvenation industry. This facial rejuvenation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Facial rejuvenation encompasses a range of cosmetic procedures and treatments aimed at restoring a more youthful appearance to the face. These procedures focus on minimizing visible signs of aging, including wrinkles, fine lines, sagging skin, and loss of facial volume, while enhancing skin texture, tone, and elasticity.

The primary product types in facial rejuvenation include botulinum toxin (BOTOX), soft tissue fillers, microabrasion equipment, chemical peels, topical skincare products, and skin rejuvenation devices. Botulinum toxin is a neurotoxic protein used in cosmetic treatments to reduce wrinkles and fine lines by temporarily relaxing facial muscles. Treatments are delivered through various methods, such as medications, injectables, surgical procedures, and others. These procedures are utilized by a range of end-users, including hospitals and clinics, beauty centers and spas, dermatology clinics, and more.

The facial rejuvenation market includes revenues earned by entities by providing non-invasive facial rejuvenation, minimally invasive facial rejuvenation, and surgical facial rejuvenation. The market value includes the value of related goods sold by the service provider or included within the service offering. The facial rejuvenation market also includes sales of microcurrent devices, LED light therapy devices, and gua sha tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.